United States · FDA National Drug Code directory
RFA BPO Acne Treatment 2.5%
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51326-176_62739ef1-542e-449d-aaad-c98403d7f895
- Product NDC
- 51326-176
- Form
- LIQUID
- Composition / generic term
- Benzoyl Peroxide
- Labeler
- Topiderm, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20241221
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZOYL PEROXIDE — 25 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (51326-176-01) / 57 g in 1 BOTTLE · 51326-176-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →